The biological cost of mutational antibiotic resistance: any practical conclusions?
Top Cited Papers
- 4 August 2006
- journal article
- review article
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 9 (5), 461-465
- https://doi.org/10.1016/j.mib.2006.07.002
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosisScience, 2006
- Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genesProceedings of the National Academy of Sciences, 2006
- A Mathematical Model Quantifying the Impact of Antibiotic Exposure and Other Interventions on the Endemic Prevalence of Vancomycin‐Resistant EnterococciThe Journal of Infectious Diseases, 2005
- Fitness Cost Due to Mutations in the 16S rRNA Associated with Spectinomycin Resistance in Chlamydia psittaci 6BCAntimicrobial Agents and Chemotherapy, 2005
- Novel Mechanism of Resistance to Oxazolidinones, Macrolides, and Chloramphenicol in Ribosomal Protein L4 of the PneumococcusAntimicrobial Agents and Chemotherapy, 2005
- Relative Fitness of Fluoroquinolone-resistantStreptococcus pneumoniaeEmerging Infectious Diseases, 2005
- Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?Journal of Antimicrobial Chemotherapy, 2005
- Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotypeFEMS Immunology & Medical Microbiology, 2004
- Effect of Macrolide Consumption on Erythromycin Resistance in Streptococcus pyogenes in Finland in 1997-2001Clinical Infectious Diseases, 2004
- The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burdenJournal of Antimicrobial Chemotherapy, 2003